Variables | Number (n = 31) |
---|---|
Gender, male (%) | 14 (45.2%) |
Agea | 56.00 (52.00, 64.00) |
MG | 4 (12.9%) |
Tumor size (cm)a | 5.75 (4.50, 8.88) |
First-line treatment | |
VATS | 17 (54.8%) |
Sternotomy | 8 (25.8%) |
Chemotherapy | 6 (19.4%) |
Mosaoka-Koga stage | |
I | 11 (35.5%) |
II | 7 (22.6%) |
III | 5 (16.1%) |
IV | 8 (25.8%) |
WHO classification | |
A | 4 (12.9%) |
AB | 7 (22.6%) |
B1 | 2 (6.5%) |
B2 | 9 (29.0%) |
B3 | 1 (3.2%) |
Carcinoma | 8 (25.8%) |